Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 526

1.

A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutation.

Kosaka T, Hongo H, Aimono E, Matsumoto K, Hayashida T, Mikami S, Nishihara H, Oya M.

Pathol Int. 2019 Oct 20. doi: 10.1111/pin.12860. [Epub ahead of print]

PMID:
31631483
2.

Real-world experience of 12-week DAA regimen of glecaprevir and pibrentasvir in patients with chronic HCV infection.

Toyoda H, Atsukawa M, Watanabe T, Nakamuta M, Uojima H, Nozaki A, Takaguchi K, Fujioka S, Iio E, Shima T, Akahane T, Fukunishi S, Asano T, Michitaka K, Tsuji K, Abe H, Mikami S, Okubo H, Okubo T, Shimada N, Ishikawa T, Moriya A, Tani J, Morishita A, Ogawa C, Tachi Y, Ikeda H, Yamashita N, Yasuda S, Chuma M, Tsutsui A, Hiraoka A, Ikegami T, Genda T, Tsubota A, Masaki T, Tanaka Y, Iwakiri K, Kumada T.

J Gastroenterol Hepatol. 2019 Oct 14. doi: 10.1111/jgh.14874. [Epub ahead of print]

PMID:
31609495
3.

Quantitative analyses of jaw-opening muscle activity during the active phase of jaw-closing muscles in sleep bruxism.

Maeda M, Yamaguchi T, Mikami S, Yachida W, Saito T, Sakuma T, Nakamura H, Saito M, Mizuno M, Yamada K, Satoh K.

J Sleep Res. 2019 Oct 1:e12922. doi: 10.1111/jsr.12922. [Epub ahead of print]

PMID:
31573129
4.

Remarkable effect of presurgical nivolumab on originally inoperable papillary renal cell carcinoma with tumor thrombus in inferior vena cava.

Shinagawa T, Ito H, Sakai Y, Mikami S, Oe H, Taga M, Yokoyama O.

Int Cancer Conf J. 2019 Jun 18;8(4):170-174. doi: 10.1007/s13691-019-00379-1. eCollection 2019 Oct.

PMID:
31559117
5.

Rational discovery of a highly novel and selective mTOR inhibitor.

Jin S, Mikami S, Scorah N, Chen Y, Halkowycz P, Shi L, Kahana J, Vincent P, de Jong R, Atienza J, Fabrey R, Zhang L, Lardy M.

Bioorg Med Chem Lett. 2019 Nov 1;29(21):126659. doi: 10.1016/j.bmcl.2019.126659. Epub 2019 Sep 3.

PMID:
31543303
6.

Validation of prognostic impact of number of extrathoracic metastases according to the eighth TNM classification: a single-institution retrospective study in Japan.

Sakai K, Kuramoto J, Kojima A, Nishimura H, Kuwabara Y, Toda M, Kobayashi Y, Kikuchi S, Hirata Y, Mikami-Saito Y, Mikami S, Kyoyama H, Moriyama G, Gemma A, Uematsu K.

Int J Clin Oncol. 2019 Aug 26. doi: 10.1007/s10147-019-01525-8. [Epub ahead of print]

PMID:
31452019
7.

A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma.

Shigeta K, Kikuchi E, Abe T, Hagiwara M, Ogihara K, Anno T, Umeda K, Baba Y, Sanjo T, Shojo K, Mikami S, Mizuno R, Oya M.

Eur Urol Oncol. 2019 Aug 5. pii: S2588-9311(19)30102-6. doi: 10.1016/j.euo.2019.06.021. [Epub ahead of print]

PMID:
31395480
8.

Evaluation of the total adenylate (ATP + ADP + AMP) test for cleaning verification in healthcare settings.

Bakke M, Suzuki S, Kirihara E, Mikami S.

J Prev Med Hyg. 2019 Jun 28;60(2):E140-E146. doi: 10.15167/2421-4248/jpmh2019.60.2.1122. eCollection 2019 Jun.

9.

Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy.

Watanabe K, Kosaka T, Aimono E, Hongo H, Mikami S, Nishihara H, Oya M.

Clin Genitourin Cancer. 2019 Oct;17(5):e897-e902. doi: 10.1016/j.clgc.2019.06.005. Epub 2019 Jun 13. No abstract available.

PMID:
31296452
10.

Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naïve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in Japan.

Ikeda H, Watanabe T, Atsukawa M, Toyoda H, Takaguchi K, Nakamuta M, Matsumoto N, Okuse C, Tada T, Tsutsui A, Yamashita N, Kondo C, Hayama K, Kato K, Itokawa N, Arai T, Shimada N, Asano T, Uojima H, Ogawa C, Mikami S, Ikegami T, Fukunishi S, Asai A, Iio E, Tsubota A, Hiraoka A, Nozaki A, Okubo H, Tachi Y, Moriya A, Oikawa T, Matsumoto Y, Tsuruoka S, Tani J, Kikuchi K, Iwakiri K, Tanaka Y, Kumada T.

J Viral Hepat. 2019 Nov;26(11):1266-1275. doi: 10.1111/jvh.13170. Epub 2019 Aug 9.

PMID:
31278795
11.

TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells.

Niwa N, Tanaka N, Hongo H, Miyazaki Y, Takamatsu K, Mizuno R, Kikuchi E, Mikami S, Kosaka T, Oya M.

Lab Invest. 2019 Nov;99(11):1702-1713. doi: 10.1038/s41374-019-0285-y. Epub 2019 Jul 1.

PMID:
31263157
12.

Trends and Efficacy of Interferon-Free Anti-hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan.

Toyoda H, Atsukawa M, Uojima H, Nozaki A, Tamai H, Takaguchi K, Fujioka S, Nakamuta M, Tada T, Yasuda S, Chuma M, Senoh T, Tsutsui A, Yamashita N, Hiraoka A, Michitaka K, Shima T, Akahane T, Itobayashi E, Watanabe T, Ikeda H, Iio E, Fukunishi S, Asano T, Tachi Y, Ikegami T, Tsuji K, Abe H, Kato K, Mikami S, Okubo H, Shimada N, Ishikawa T, Matsumoto Y, Itokawa N, Arai T, Tsubota A, Iwakiri K, Tanaka Y, Kumada T.

Open Forum Infect Dis. 2019 Apr 15;6(5):ofz185. doi: 10.1093/ofid/ofz185. eCollection 2019 May.

13.

Japanese patient preferences regarding intermediate to advanced hepatocellular carcinoma treatments.

Chiba T, Hiraoka A, Mikami S, Shinozaki M, Osaki Y, Obu M, Ohki T, Mita N, Ledesma D, Yoshihara N, Beusterien K, Amos K, Bridges JF, Yokosuka O.

Patient Prefer Adherence. 2019 Apr 30;13:637-647. doi: 10.2147/PPA.S198363. eCollection 2019.

14.

Validity of single-channel masseteric electromyography by using an ultraminiature wearable electromyographic device for diagnosis of sleep bruxism.

Maeda M, Yamaguchi T, Mikami S, Yachida W, Saito T, Sakuma T, Nakamura H, Saito M, Mizuno M, Yamada K, Satoh K.

J Prosthodont Res. 2019 May 10. pii: S1883-1958(18)30462-6. doi: 10.1016/j.jpor.2019.04.003. [Epub ahead of print]

PMID:
31085074
15.

Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients.

Takamatsu K, Mizuno R, Tanaka N, Takeda T, Morita S, Matsumoto K, Kosaka T, Shinojima T, Kikuchi E, Asanuma H, Oyama M, Mikami S, Oya M.

Int J Clin Oncol. 2019 Sep;24(9):1069-1074. doi: 10.1007/s10147-019-01459-1. Epub 2019 May 7.

PMID:
31065836
16.

Resveratrol‑induced REG III expression enhances chemo‑ and radiosensitivity in head and neck cancer in xenograft mice.

Mikami S, Ota I, Masui T, Uchiyama T, Okamoto H, Kimura T, Takasawa S, Kitahara T.

Oncol Rep. 2019 Jul;42(1):436-442. doi: 10.3892/or.2019.7137. Epub 2019 Apr 25.

PMID:
31059079
17.

An Investigation of Factors Related to Food Intake Ability and Swallowing Difficulty After Surgery for Thoracic Esophageal Cancer.

Mafune T, Mikami S, Otsubo T, Saji O, Matsushita T, Enomoto T, Maki F, Tochimoto S.

Dysphagia. 2019 Aug;34(4):592-599. doi: 10.1007/s00455-019-10010-3. Epub 2019 Apr 29.

18.

Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma.

Mikami S, Mizuno R, Kondo T, Shinohara N, Nonomura N, Ozono S, Eto M, Tatsugami K, Takayama T, Matsuyama H, Kishida T, Oya M; Japanese Society of Renal Cancer.

Cancer Sci. 2019 Jun;110(6):1820-1828. doi: 10.1111/cas.14019. Epub 2019 May 13.

19.

Guidance for in situ gamma spectrometry intercomparison based on the information obtained through five intercomparisons during the Fukushima mapping project.

Mikami S, Ishikawa D, Matsuda H, Hoshide Y, Okuda N, Sakamoto R, Saito K.

J Environ Radioact. 2019 Mar 23:105938. doi: 10.1016/j.jenvrad.2019.03.014. [Epub ahead of print]

20.

The deposition densities of radiocesium and the air dose rates in undisturbed fields around the Fukushima Dai-ichi nuclear power plant; their temporal changes for five years after the accident.

Mikami S, Tanaka H, Matsuda H, Sato S, Hoshide Y, Okuda N, Suzuki T, Sakamoto R, Andoh M, Saito K.

J Environ Radioact. 2019 Mar 23:105941. doi: 10.1016/j.jenvrad.2019.03.017. [Epub ahead of print]

21.

Sulfasalazine could modulate the CD44v9-xCT system and enhance cisplatin-induced cytotoxic effects in metastatic bladder cancer.

Ogihara K, Kikuchi E, Okazaki S, Hagiwara M, Takeda T, Matsumoto K, Kosaka T, Mikami S, Saya H, Oya M.

Cancer Sci. 2019 Apr;110(4):1431-1441. doi: 10.1111/cas.13960. Epub 2019 Mar 1.

22.

Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at risk.

Weiss A, Grossmith S, Cutts D, Mikami SA, Suskin JA, Graichen MK, Rojas NA, Pace LE, Joyce E, Rhei E, Scheib R, Bychkovsky B, Garber JE, Morganstern D, King TA.

Breast Cancer Res Treat. 2019 May;175(1):229-237. doi: 10.1007/s10549-018-05116-5. Epub 2019 Jan 21.

PMID:
30666540
23.

Summary of temporal changes in air dose rates and radionuclide deposition densities in the 80 km zone over five years after the Fukushima Nuclear Power Plant accident.

Saito K, Mikami S, Andoh M, Matsuda N, Kinase S, Tsuda S, Yoshida T, Sato T, Seki A, Yamamoto H, Sanada Y, Wainwright-Murakami H, Takemiya H.

J Environ Radioact. 2019 Jan 10:105878. doi: 10.1016/j.jenvrad.2018.12.020. [Epub ahead of print]

24.

Evaluation of prostate-specific antigen density in the diagnosis of prostate cancer combined with magnetic resonance imaging before biopsy in men aged 70 years and older with elevated PSA.

Yanai Y, Kosaka T, Hongo H, Matsumoto K, Shinojima T, Kikuchi E, Miyajima A, Mizuno R, Mikami S, Jinzaki M, Oya M.

Mol Clin Oncol. 2018 Dec;9(6):656-660. doi: 10.3892/mco.2018.1725. Epub 2018 Sep 19.

25.

Immunoglobulin G4-Related Disease Arising from the Bladder Wall.

Kufukihara R, Niwa N, Mizuno R, Ohara K, Mikami S, Kikuchi E, Oya M.

Urol Int. 2018 Dec 13:1-3. doi: 10.1159/000495570. [Epub ahead of print]

PMID:
30544121
26.

Post-transplant lymphoproliferative disorder of the cauda equina in a kidney transplant recipient.

Nishiyama Y, Iwanami A, Mikami S, Kawabata S, Tsuji O, Nagoshi N, Okada E, Fujita N, Yagi M, Ishii K, Matsumoto M, Nakamura M, Watanabe K.

Spinal Cord Ser Cases. 2018 Nov 6;4:100. doi: 10.1038/s41394-018-0135-y. eCollection 2018.

27.

Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma.

Ito K, Masunaga A, Tanaka N, Mizuno R, Shirotake S, Yasumizu Y, Ito Y, Miyazaki Y, Hagiwara M, Kanao K, Mikami S, Momma T, Masuda T, Nakagawa K, Oyama M, Asano T, Oya M.

Jpn J Clin Oncol. 2019 Jan 1;49(1):69-76. doi: 10.1093/jjco/hyy154.

PMID:
30407543
28.

Severe headache in a patient with meningioma showing extensive dural tail correlates with IgG4-positive plasma cells and eosinophils: A case report and review of literature.

Kuranari Y, Tamura R, Mikami S, Ohara K, Toda M, Yoshida K.

Surg Neurol Int. 2018 Oct 8;9:202. doi: 10.4103/sni.sni_231_18. eCollection 2018.

29.

Single-cell RNA-seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63.

Tanaka N, Katayama S, Reddy A, Nishimura K, Niwa N, Hongo H, Ogihara K, Kosaka T, Mizuno R, Kikuchi E, Mikami S, Miyakawa A, Arenas E, Kere J, Oya M, Uhlén P.

Cancer Med. 2018 Dec;7(12):6193-6204. doi: 10.1002/cam4.1828. Epub 2018 Oct 26.

30.

Ureteral pseudodiverticulosis accompanied by urothelial carcinoma diagnosed by CT urography: a case report and review of the literature.

Sugiura H, Akita H, Kikuchi E, Mikami S, Hayakawa N, Narita K, Jinzaki M.

BJR Case Rep. 2018 Jan 18;4(2):20170111. doi: 10.1259/bjrcr.20170111. eCollection 2018.

31.

Decreasing trend of ambient dose equivalent rates over a wide area in eastern Japan until 2016 evaluated by car-borne surveys using KURAMA systems.

Andoh M, Mikami S, Tsuda S, Yoshida T, Matsuda N, Saito K.

J Environ Radioact. 2018 Oct 19:105813. doi: 10.1016/j.jenvrad.2018.09.011. [Epub ahead of print]

PMID:
30348530
32.

Characterizing regional-scale temporal evolution of air dose rates after the Fukushima Daiichi Nuclear Power Plant accident.

Wainwright HM, Seki A, Mikami S, Saito K.

J Environ Radioact. 2018 Oct 15:105808. doi: 10.1016/j.jenvrad.2018.09.006. [Epub ahead of print]

PMID:
30337102
33.

Efficacy of direct-acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study.

Itokawa N, Atsukawa M, Tsubota A, Ikegami T, Shimada N, Kato K, Abe H, Okubo T, Arai T, Iwashita AN, Kondo C, Mikami S, Asano T, Matsuzaki Y, Toyoda H, Kumada T, Iio E, Tanaka Y, Iwakiri K.

Hepatol Res. 2019 Feb;49(2):125-135. doi: 10.1111/hepr.13256. Epub 2018 Nov 13.

PMID:
30307682
34.

Clinical Outcomes in Patients With Metastatic Papillary Renal-Cell Carcinoma: A Multi-Institutional Study in Japan.

Ito K, Mikami S, Tatsugami K, Masumori N, Shinohara N, Kondo T, Nakanishi S, Nagashima Y, Eto M, Kamba T, Kuroda N, Tomita Y, Matsuyama H, Onishi T, Tsushima T, Nakazawa H, Oya M, Ozono S, Naito S, Asano T.

Clin Genitourin Cancer. 2018 Dec;16(6):e1201-e1214. doi: 10.1016/j.clgc.2018.07.028. Epub 2018 Aug 11.

PMID:
30224330
35.

Acute regrowth and dissemination of a mature spinal cord teratoma after partial resection.

Kawai M, Nagoshi N, Iwanami A, Mikami S, Tsuji O, Fujita N, Yagi M, Watanabe K, Ishii K, Nakamura M, Matsumoto M.

BMJ Case Rep. 2018 Sep 1;2018. pii: bcr-2017-223742. doi: 10.1136/bcr-2017-223742.

PMID:
30173127
36.

IgG4-related mastopathy: A case report and literature review.

Yokoe T, Hayashida T, Kikuchi M, Watanuki R, Nakashoji A, Maeda H, Toyota T, Seki T, Takahashi M, Iwasaki E, Mikami S, Kameyama K, Kitagawa Y.

Clin Case Rep. 2018 Jun 22;6(8):1549-1553. doi: 10.1002/ccr3.1657. eCollection 2018 Aug.

37.

Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.

Atsukawa M, Tsubota A, Toyoda H, Takaguchi K, Kondo C, Okubo T, Hiraoka A, Michitaka K, Fujioka S, Uojima H, Watanabe T, Ikeda H, Asano T, Ishikawa T, Matsumoto Y, Abe H, Kato K, Tsuji K, Ogawa C, Shimada N, Iio E, Mikami S, Tanaka Y, Kumada T, Iwakiri K.

J Gastroenterol Hepatol. 2019 Feb;34(2):364-369. doi: 10.1111/jgh.14447. Epub 2018 Sep 14.

PMID:
30144366
38.

Performance of diffusion-weighted MRI post-CT urography for the diagnosis of upper tract urothelial carcinoma: Comparison with selective urine cytology sampling.

Akita H, Kikuchi E, Hayakawa N, Mikami S, Sugiura H, Oya M, Jinzaki M.

Clin Imaging. 2018 Nov - Dec;52:208-215. doi: 10.1016/j.clinimag.2018.08.012. Epub 2018 Aug 16.

PMID:
30125847
39.

Decreasing trend of ambient dose equivalent rates over a wide area in eastern Japan until 2016 evaluated by car-borne surveys using KURAMA systems.

Andoh M, Mikami S, Tsuda S, Yoshida T, Matsuda N, Saito K.

J Environ Radioact. 2018 Dec;192:385-398. doi: 10.1016/j.jenvrad.2018.07.009. Epub 2018 Jul 23.

PMID:
30048901
40.

Endothelial Dysfunction, Increased Arterial Stiffness, and Cardiovascular Risk Prediction in Patients With Coronary Artery Disease: FMD-J (Flow-Mediated Dilation Japan) Study A.

Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Iwamoto A, Kajikawa M, Matsumoto T, Oda N, Kishimoto S, Matsui S, Hashimoto H, Aibara Y, Mohamad Yusoff F, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y.

J Am Heart Assoc. 2018 Jul 12;7(14). pii: e008588. doi: 10.1161/JAHA.118.008588.

41.

PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancer.

Yasumizu Y, Hongo H, Kosaka T, Mikami S, Nishimoto K, Kikuchi E, Oya M.

Oncotarget. 2018 Jun 12;9(45):27698-27707. doi: 10.18632/oncotarget.25498. eCollection 2018 Jun 12.

42.

Lymph node density in papillary thyroid carcinoma is a prognostic factor after adjusting for pathological stage.

Suzuki H, Koide Y, Hanai N, Nishikawa D, Beppu S, Mikami S, Hasegawa Y.

Oncotarget. 2018 Jun 1;9(42):26670-26678. doi: 10.18632/oncotarget.25453. eCollection 2018 Jun 1.

43.

Augmented rectangle technique for Billroth I anastomosis in totally laparoscopic distal gastrectomy for gastric cancer.

Fukunaga T, Ishibashi Y, Oka S, Kanda S, Yube Y, Kohira Y, Matsuo Y, Mori O, Mikami S, Enomoto T, Otsubo T.

Surg Endosc. 2018 Sep;32(9):4011-4016. doi: 10.1007/s00464-018-6266-1. Epub 2018 Jun 18.

PMID:
29915985
44.

Triple-stapled quadrilateral anastomosis: a new technique for creation of an esophagogastric anastomosis.

Ishibashi Y, Fukunaga T, Mikami S, Oka S, Kanda S, Yube Y, Kohira Y, Enomoto T, Otsubo T.

Esophagus. 2018 Apr;15(2):88-94. doi: 10.1007/s10388-017-0599-z. Epub 2017 Dec 16.

45.

[Diagnostic utility of endoscopic ultrasonography elastography and contrast-enhanced harmonic endoscopic ultrasonography in a patient with type 2 autoimmune pancreatitis].

Yokode M, Shiomi H, Itai R, Mikami S, Yamashita Y, Nakano R, Ezaki T, Masuda A, Zen Y.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(6):563-572. doi: 10.11405/nisshoshi.115.563. Japanese.

PMID:
29887592
46.

Fistula Formation Secondary to Mucinous Appendiceal Adenocarcinoma May Be Related to a Favorable Prognosis: A Case Report and Literature Review.

Yokode M, Ikeda E, Matsui Y, Iwamura S, Mikami S, Kobayashi H, Imai Y, Kaihara S, Yamashita Y.

Intern Med. 2018 Oct 15;57(20):2945-2949. doi: 10.2169/internalmedicine.0694-17. Epub 2018 Jun 6. Review.

47.

Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan.

Toyoda H, Atsukawa M, Takaguchi K, Senoh T, Michitaka K, Hiraoka A, Fujioka S, Kondo C, Okubo T, Uojima H, Tada T, Yoneyama H, Watanabe T, Asano T, Ishikawa T, Tamai H, Abe H, Kato K, Tsuji K, Ogawa C, Shimada N, Iio E, Deguchi A, Itobayashi E, Mikami S, Moriya A, Okubo H, Tani J, Tsubota A, Tanaka Y, Masaki T, Iwakiri K, Kumada T.

J Gastroenterol. 2018 Dec;53(12):1276-1284. doi: 10.1007/s00535-018-1473-z. Epub 2018 May 8.

PMID:
29740665
48.

Clinical Role of Programmed Cell Death-1 Expression in Patients with Non-muscle-invasive Bladder Cancer Recurring After Initial Bacillus Calmette-Guérin Therapy.

Fukumoto K, Kikuchi E, Mikami S, Hayakawa N, Matsumoto K, Niwa N, Oya M.

Ann Surg Oncol. 2018 Aug;25(8):2484-2491. doi: 10.1245/s10434-018-6498-2. Epub 2018 May 1.

PMID:
29717423
49.

Characterizing regional-scale temporal evolution of air dose rates after the Fukushima Daiichi Nuclear Power Plant accident.

Wainwright HM, Seki A, Mikami S, Saito K.

J Environ Radioact. 2018 Sep;189:213-220. doi: 10.1016/j.jenvrad.2018.04.006. Epub 2018 Apr 24.

PMID:
29702453
50.

Prognostic Value of Baseline Serum C-Reactive Protein Level in Intermediate-Risk Group Patients With Metastatic Renal-Cell Carcinoma Treated by First-Line Vascular Endothelial Growth Factor-Targeted Therapy.

Takamatsu K, Mizuno R, Omura M, Morita S, Matsumoto K, Shinoda K, Kosaka T, Takeda T, Shinojima T, Kikuchi E, Asanuma H, Oyama M, Mikami S, Oya M.

Clin Genitourin Cancer. 2018 Aug;16(4):e927-e933. doi: 10.1016/j.clgc.2018.03.012. Epub 2018 Mar 27.

PMID:
29678472

Supplemental Content

Loading ...
Support Center